...
首页> 外文期刊>Pharmaceutical Nanotechnology >Transfection Optimization of Hyperbranched Poly 2-Dimethylaminoethyl Methacrylate (pDMAEMA) based Polymers In Vitro
【24h】

Transfection Optimization of Hyperbranched Poly 2-Dimethylaminoethyl Methacrylate (pDMAEMA) based Polymers In Vitro

机译:基于超支化聚甲基丙烯酸2-二甲氨基乙基酯(pDMAEMA)的聚合物的转染优化

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The present study reports the transfection and cytotoxicity of hyperbranched poly (2-dimethyl-aminoethylmethacrylate) (pDMAEMA) based polymer at various physiological conditions. Transfection capability and cytotoxicity of the hyperbranched polymer were first evaluated by varying the molecular weight upon PEGylation. Hyperbranched polymer with optimal PEGylation was later protonized and the effect of protonation was evaluated. Finally, the effects of serum on transfection and cellular metabolic activity on various cell types were investigated. Results suggest that hyperbranched polymer with medium PEGylation (Mw 24000Da) and protonation were best suited for transfection which exhibited minimal toxicity. However, the effect of serum was cell-type dependent.
机译:本研究报告了在各种生理条件下,超支化聚(2-甲基丙烯酸甲基丙烯酸二甲酯)(pDMAEMA)聚合物的转染和细胞毒性。首先通过改变PEG化后的分子量来评估超支化聚合物的转染能力和细胞毒性。随后将具有最佳PEG化的超支化聚合物质子化,并评估质子化的效果。最后,研究了血清对各种细胞类型的转染和细胞代谢活性的影响。结果表明,具有中等PEG化(Mw 24000Da)和质子化的超支化聚合物最适合显示最小毒性的转染。但是,血清的作用取决于细胞类型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号